[English]  [Pусский]  [中文]  
 
ctt-journal > Vinogradov et al. (Abstract)

Vinogradov et al. (Abstract)

Cellular Therapy and Transplantation (CTT), Vol. 3, No. 9
doi: 10.3205/ctt-2010-No9-abstract05
© The Authors. This abstract is provided under the following license: Creative Commons Attribution 3.0 Unported

Abstract accepted for "4th Raisa Gorbacheva Memorial Meeting on Hematopoietic Stem Cell Transplantation",
Saint Petersburg, Russia, September 18–20, 2010

Contribute a comment

 

TP53 gene point mutation detection using sequencing techniques in acute and chronic leukemia patients

Alexander V. Vinogradov, Alexey V. Rezaikin, Alexander G. Sergeev

Ural State Medical Academy, Ekaterinburg, Russia

Correspondence: Alexander V. Vinogradov, Ural State Medical Academy, 3, Repina str., 620028, Ekaterinburg, Russia, E-mail: vinogradov-av@spam is badya.ru

Abstract

Aim: TP53 gene point mutation detection in acute and chronic leukemia patients by using sequencing methods.

Patients and methods: 24 patients were included in the study, among which were 6 pts with AML, 9 with ALL, 6 with CML, 1 with idiopathic myelofibrosis, and 1 with aggressive lymphoma. TP53 gene point mutation detection was realized via the sequencing method. The extraction of mRNA was made from bone marrow material and peripheral blood neoplastic cells. Sequences of primers for TP53 gene amplification (exons 4–11) using a polymerase chain reaction technique are represented in table 1.

Table 1.

Primer

Sequence

Position

P53-F

5' AGT CAG ATC CTA GCG TCG AG 3'

211–230

P53-R

5' TGG CGG GAG GTA GAC TG 3'

1320–1336


Primers for the termination reaction for amplified TP53 gene loci were chosen using highly conservative and specific mRNA nucleotide sequences represented in the GenBank (table 2).

Table 2.

Primer

Sequence

Position

P53-S1

5' ACA TTT TCA GAC CTA TGG AA 3'

249–268

P53-S2

5' GCG CCA TGG CCA TCT ACA AG 3'

670–689

P53-S3

5' ACC CTT TTT GGA CTT CAG GT 3'

1300–13


Sequencing was realized via an automatic genetic analyzer ABI Prism 310 using reactive components and an ABI Prism BigDye Terminator Cycle Sequencing Kit v. 3.0 (Applied Biosystem, USA).

Results: All patients from the research group except one with CLL showed the nucleotide change C215G (cytosine for guanine in position 215), which leads to a change of amino acid proline for arginine in position 72 (P72R) in the determining protein. In one case the variant of gene TP53 according to wild type (NM_000546, GenBank NCBI) was detected.

Keywords: TP53 gene, sequencing, leukemia, C215G nucleotide change

<-- Previous abstract        Contents        Next abstract -->

Contribute a comment

Top